Now at Sheba – Revolutionary SRT-100 Vision System from Sensus Healthcare
Sensus Healthcare recently sent its SRT-100 Vision system to Sheba Medical Center. This advanced device uses Image-Guided Superficial Radiation Therapy (IGSRT) to enable the non-invasive treatment of non-melanoma skin cancers (NMSC). The new SRT-100 Vision system unit is the third of its kind in Israel, with the other two installed previously at Ichilov Hospital in Tel Aviv and Beilinson Hospital in Petah Tikva.
“Having the SRT-100 Vision system at Sheba Medical Center, the largest hospital in the country and a significant member of the global medical community, furthers Sensus’s mission to make this breakthrough treatment available around the world,” said Joe Sardano, CEO of Sensus Healthcare.
The SRT-100 Vision system evaluates basal and squamous cell carcinomas and keloid tissue with targeted and precise treatment. Also, the LesionCam records each session, which enables doctors to closely track any changes in the lesion and customize treatment accordingly.
Sensus recently opened a new office in Tel Aviv – thereby expanding their footprint in the region. As their business in Israel grows, they are tapping into the country’s innovative skills as well as meeting increased patient demand for a painless, non-invasive option for non-melanoma skin cancer and keloid treatment. Thousands of patients have already benefited from Sensus’s safe and effective technology, and Sheba Medical Center is pleased to make this treatment available to even more people.